Skip Fleshman
Partner at Aulis Capital · San Francisco, United States
Invests in AIAI is one of the sectors on Skip Fleshman's investor profile, next to Healthcare & Biotech and Digital Health & HealthTech, at pre-seed and seed. The record holds 58 deals, including Indi Molecular, ICON Aircraft and CardioGen Sciences.
Email InvestorCredits to line up before a pre-seed round
Skip Fleshman backs companies at pre-seed and seed. A few of the larger credit programs on AI Perks for teams at that point:
Portfolio on record
Portfolio companies
- Indi Molecular
- ICON Aircraft
- CardioGen Sciences
- Chimerix
- CardioDx
- Autonomize AI
- Esperion Therapeutics
- LiquidM
- The Activity Exchange (AchieveMint)
- Signal Vine
- Provade, Inc.
- Proteus Digital Health
- OfferIQ
- Carta Healthcare
- RallyPoint
- Welldoc
- Freenome
- Audentes Therapeutics
- Servo Software
- InCarda Therapeutics
- Rapidscan Pharma Solutions
- Unnatural Products
- Maverix Biomics
- Huiseoul
- HealthTap
- Tradeo
- Arterys
- Ooma
- Mightier
- ViewPoint Therapeutics
- Aegis Surgical
- Stratavia
- Benefitter
- Properly
- Biomimedica
- Profusa
- Thunder
- Mozio
- Sensomics
- Amygdala Neuroscience
- ImmunoCellular Therapeutics
- Care Access
- Outcomes4Me
- Evidation Health
- Lark
- Womply
- Twist Bioscience
- Terra Bella
- UniKey Technologies
- Keepsafe
Showing 50 of 58 deals on record.
Investment focus
- Backs startups in
- Artificial Intelligence, Healthcare & Biotech, Digital Health & HealthTech
- Rounds
- Pre-seed, Seed
- Profile
- Venture investor
- Deals on record
- 58
- Based in
- San Francisco, United States

Ready to pitch AI investors?
AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.
Email InvestorMore AI investors on AI Perks
- Esther DysonAngel investor in New York City
- Ullas NaikFounder and General Partner at Streamlined
- Alex IskoldFounder and Partner at 2048 Ventures
- Lonne JaffeManaging Director at Insight Partners
- Nikitas KoutoupesManaging Director at Insight Partners
- Dev KharePartner at Lightspeed India
- Anis UzzamanVenture investor in San Jose
- Eric RiesAngel investor in San Francisco
Questions founders ask
- Does Skip Fleshman invest in AI startups?
- Yes. Artificial Intelligence is one of the sectors on Skip Fleshman's investor profile, together with Healthcare & Biotech and Digital Health & HealthTech. The stages on record are pre-seed and seed.
- Which companies has Skip Fleshman backed?
- The record lists 58 deals, including Indi Molecular, ICON Aircraft, CardioGen Sciences, Chimerix and CardioDx. None of them has a perk listed on AI Perks yet.
- What credits can a startup claim before pitching Skip Fleshman?
- For a company raising a pre-seed round, AI Perks lists credits such as Amazon Bedrock (up to $200,000), Massdriver (up to $20,000), AssemblyAI (up to $150,000) and Beefree SDK (up to $10,000), with each program's terms and how to apply.
- Does AI Perks publish investor contact details?
- No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor
Source: public professional information. Is this you? Request removal